Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

3 Class I (most serious) drug recalls reported in the last 30 days.

3,250 recalls

  • Class I Terminated

    Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans, Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, U…

    Reason: Chemical contamination: presence of benzene

    The Procter & Gamble Company

    Lots, distribution and details
    Product
    Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans, Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7
    Lots / codes
    Lot #: 12081458SB, Exp 6/30/2021; 92181458FA, Exp 7/31/21;
    Distribution
    Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
    Quantity
    unknown
    Recall started
    November 23, 2021 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0240-2024
  • Class II Terminated

    Old Spice, SWEAT DEFENSE, STRONGER SWAGGER, Dry Spray, 48 Hour, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical Spray Can, Net WT 3.8 oz (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC 69423-386-…

    Reason: CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene

    The Procter & Gamble Company

    Lots, distribution and details
    Product
    Old Spice, SWEAT DEFENSE, STRONGER SWAGGER, Dry Spray, 48 Hour, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical Spray Can, Net WT 3.8 oz (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC 69423-386-10, UPC 0 37000 73034 7 OR UPC 0 12044 04475 9 (12 Pack, older label)
    Lots / codes
    All lots with expiry through September 2023,
    Distribution
    Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
    Quantity
    unknown
    Recall started
    November 23, 2021 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0239-2024
  • Class I Terminated

    Old Spice, PURE SPORT, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant & Deodorant Spray, Topical spray can, Net WT 6.0 OZ (170g), Distributed by Procter & Gamble, Cincinnati, OH 45202. NDC: 37000-199-60, UPC 0 12044 001…

    Reason: Chemical contamination: presence of benzene

    The Procter & Gamble Company

    Lots, distribution and details
    Product
    Old Spice, PURE SPORT, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant & Deodorant Spray, Topical spray can, Net WT 6.0 OZ (170g), Distributed by Procter & Gamble, Cincinnati, OH 45202. NDC: 37000-199-60, UPC 0 12044 00191 2
    Lots / codes
    Lot #: 11661458SM, 11681458SB, Exp 5/31/23; 12621458SV, 12631458SB, Exp 08/31/23
    Distribution
    Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana
    Quantity
    unknown
    Recall started
    November 23, 2021 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0238-2024
  • Class II Ongoing

    Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90

    Reason: Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.

    Ascend Laboratories, LLC · Ibuprofen and Famotidine

    Lots, distribution and details
    Lots / codes
    23140190, Exp. Date 12/31/2024
    Distribution
    Nationwide
    Quantity
    3,288 bottles
    Recall started
    December 29, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0237-2024
  • Class I Completed

    Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736…

    Reason: Chemical Contamination: presence of benzene

    Insight Pharmaceuticals LLC, a Prestige Consumer Healthcare company · Benzocaine

    Lots, distribution and details
    Product
    Americaine, (benzocaine 20%) Benzocaine Topical Anesthetic Spray, Aerosol Can 2 oz (57 G), Dist. by Insight Pharmaceuticals Corp. Tarrytown, NY 10591, USA, A Prestige Consumer Healthcare company. Made in India. NDC 63736-378-02, Can UPC 3 63736 37882 0; Case UPC 1 03 63736 37882 7
    Lots / codes
    Lot # 1A16420, exp. date 01/31/2025
    Distribution
    Nationwide in the USA
    Quantity
    34,704 cans
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0236-2024
  • Class I Ongoing

    Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (ca…

    Reason: Presence of Particulate Matter; identified as glass

    Pfizer Inc. · Atropine Sulfate

    Lots, distribution and details
    Product
    Atropine Sulfate Injection, USP 1 mg/10 mL (0.1 mg/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake FOrest, IL 60045, NDC 0409-4911-11 (carton), 0409-4911-34 (case).
    Lots / codes
    Lot GY2496, Exp 02/01/2025
    Distribution
    Nationwide in the USA and Puerto Rico.
    Quantity
    24400 Cartons
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0235-2024
  • Class I Ongoing

    8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-66…

    Reason: Presence of Particulate Matter; identified as glass

    Pfizer Inc. · Sodium Bicarbonate

    Lots, distribution and details
    Product
    8.4 % Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL), Lifeshield, Glass ABBOJECT Unit of Use Syringe, Rx Only, 50 mL Syringe per Carton, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6637-24 (carton), 0409-6637-14 (case).
    Lots / codes
    Lot HA7295, EXP 03/01/2025
    Distribution
    Nationwide in the USA and Puerto Rico.
    Quantity
    21200 Cartons
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0234-2024
  • Class I Ongoing

    4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton),…

    Reason: Presence of Particulate Matter; identified as glass

    Pfizer Inc. · Sodium Bicarbonate

    Lots, distribution and details
    Product
    4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).
    Lots / codes
    Lot GX1542, Exp. 01/01/2025
    Distribution
    Nationwide in the USA and Puerto Rico.
    Quantity
    34000 Cartons
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0233-2024
  • Class II Ongoing

    Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Ch…

    Reason: Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.

    Par Sterile Products LLC · Vasopressin

    Lots, distribution and details
    Product
    Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-237-10
    Lots / codes
    Lot # 66702; Exp. 02/2025
    Distribution
    Nationwide USA
    Quantity
    1721 cartons
    Recall started
    January 11, 2024 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0232-2024
  • Class II Ongoing

    Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Cherry Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-312-10.

    Reason: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS – Presence of Acetobacter nitrogenifigens bacteria.

    Pharma Nobis LLC

    Lots, distribution and details
    Lots / codes
    Lot A80622; Exp. 11/2025
    Distribution
    Nationwide.
    Quantity
    7,404 Bottles
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0231-2024
  • Class II Ongoing

    Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-311-10.

    Reason: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS – Presence of Acetobacter nitrogenifigens bacteria.

    Pharma Nobis LLC

    Lots, distribution and details
    Lots / codes
    Lot A80553; Exp. 11/2025
    Distribution
    Nationwide.
    Quantity
    53,268 Bottles
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0230-2024
  • Class II Ongoing

    CVS Health Magnesium Citrate Saline Laxative Oral Solution DYE FREE Grape Flavor 10 fl. oz, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, NDC 51316-881-10.

    Reason: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS – Presence of Acetobacter nitrogenifigens bacteria.

    Pharma Nobis LLC

    Lots, distribution and details
    Lots / codes
    Lot A80763; Exp. 11/2025
    Distribution
    Nationwide.
    Quantity
    13,344 bottles
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0229-2024
  • Class II Ongoing

    Walgreens Dye-Free Magnesium Citrate Saline Laxative/Oral Solution, Sugar Free Low Sodium, Grape flavor 10 fl. oz, Distributed by: Walgreen Co, 200 Wilmot Rd, Deerfield, IL 60015, NDC 0363-0427-98.

    Reason: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS – Presence of Acetobacter nitrogenifigens bacteria.

    Pharma Nobis LLC · Magnesium Chloride

    Lots, distribution and details
    Lots / codes
    Lot A80623; Exp. 11/30/2025
    Distribution
    Nationwide.
    Quantity
    49,716 Bottles
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0228-2024
  • Class II Ongoing

    Good Neighbor Pharmacy, DYE FREE, SUGAR FREE Magnesium Citrate Saline Laxative, Oral Solution, Cherry Flavor 10 fl. oz, Distributed by AmerisourceBergen, 1 West First Ave, Conshochoken, PA 19428, NDC 46122-741-38

    Reason: MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS – Presence of Acetobacter nitrogenifigens bacteria.

    Pharma Nobis LLC · Magnesium Chloride

    Lots, distribution and details
    Lots / codes
    Lots A80673, A80742; Exp 10/31/2025
    Distribution
    Nationwide.
    Quantity
    24,684 Bottles
    Recall started
    December 21, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0227-2024
  • Class II Completed

    Tizanidine Tablets, USP 4mg, 150-count bottle, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam – 532 409 INDIA, NDC 55111-180-15

    Reason: Presence of Foreign tablets/capsules – identified as tizanidine 2 mg tablets.

    Dr. Reddy's Laboratories, Inc. · Tizanidine

    Lots, distribution and details
    Lots / codes
    Lot #: T2304007, Exp 7/31/2026
    Distribution
    USA Nationwide
    Quantity
    38,952 bottles
    Recall started
    January 2, 2024 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0223-2024
  • Class II Ongoing

    buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Tela…

    Reason: Presence of Foreign Tablets/Capsules

    Rising Pharma Holding, Inc. · Bupropion Hydrochloride

    Lots, distribution and details
    Product
    buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana – 502307, INDIA, NDC 16571-862-03
    Lots / codes
    Lot #: BPA123098A, Exp. Date 06/2025
    Distribution
    Nationwide within the United States
    Quantity
    47,976 bottles
    Recall started
    December 29, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0222-2024
  • Class II Terminated

    Desloratadine Tablets USP 5mg a) 100 count (NDC 68180-153-01) and b) 500 count (NDC 68180-153-02) bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202.

    Reason: CGMP Deviations: N-Nitroso Desloratadine impurity result exceeded the acceptable intake limit.

    Lupin Pharmaceuticals Inc. · Desloratadine

    Lots, distribution and details
    Lots / codes
    Lot # G201822, exp. date Jan 2024, 100 count G201823, exp. date Jan 2024, 100 count G201824, exp. date Jan 2024, 500 count
    Distribution
    Product was distributed nationwide.
    Quantity
    100=29,184 bottles; 500=2922 bottles
    Recall started
    December 20, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0221-2024
  • Class I Completed

    Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., War…

    Reason: Defective Container: powder may leak out of the pouch

    InvaGen Pharmaceuticals, Inc. · Vigabatrin

    Lots, distribution and details
    Product
    Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
    Lots / codes
    Lot #: NB301030, Exp. Date 03/31/2025
    Distribution
    Nationwide within the United States
    Quantity
    1240 boxes
    Recall started
    November 17, 2023 (Voluntary: Firm initiated)
    Severity
    Most serious: use could cause serious health problems or death.
    FDA recall number
    D-0220-2024
  • Class II Terminated

    Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01

    Reason: Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.

    Dr. Reddy's Laboratories, Inc. · Tacrolimus

    Lots, distribution and details
    Lots / codes
    Lot# C2307275; Exp. January 2026
    Distribution
    US Nationwide.
    Quantity
    8,280 bottles
    Recall started
    December 15, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0219-2024
  • Class II Ongoing

    DELFLEX Peritoneal Dialysis Solution in Biofine container 1.5% Dextrose, packaged in 6000mL bags, Rx only, Fresenius Medical Care NA Waltham, MA 02451, NDC 49230-206-62.

    Reason: Lack of Sterility Assurance

    Fresenius Medical Care Holdings, Inc.

    Lots, distribution and details
    Lots / codes
    Part Number: 077-60621, Lot #: 23JK02010, Exp. Date 1/31/2025
    Distribution
    Nationwide within the United States
    Quantity
    69,590 bags
    Recall started
    December 28, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0218-2024
  • Class II Ongoing

    Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-60…

    Reason: CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

    Seaway Pharma Inc. · Oxymetazoline Hydrochloride

    Lots, distribution and details
    Product
    Quality Choice No Drip Severe Congestion Nasal Pump Mist, Oxymetazoline hydrochloride 0.05%, Nasal Decongestant, 12 Hours, 1 fl. oz. bottle, Distributed by C.D.M.A., Inc., 43157 W 9 Mile Rd., Novi, MI 48375, NDC 63868-608-01, UPC 6-35515-98846-0
    Lots / codes
    Lot # SE23035, Exp 05/31/2026
    Distribution
    MI, PA
    Quantity
    8,160 bottles
    Recall started
    December 28, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0217-2024
  • Class II Ongoing

    Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-…

    Reason: CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

    Seaway Pharma Inc. · Oxymetazoline Hydrochloride

    Lots, distribution and details
    Product
    Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.
    Lots / codes
    Lot # SE23034, Exp 05/31/2026
    Distribution
    MI, PA
    Quantity
    7,992 bottles
    Recall started
    December 28, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0216-2024
  • Class II Ongoing

    Premier Value Tussin Cough DM, Dextromethorphan HBr…Cough Suppressant, Guaifenesin…Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA…

    Reason: CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

    Seaway Pharma Inc.

    Lots, distribution and details
    Product
    Premier Value Tussin Cough DM, Dextromethorphan HBr…Cough Suppressant, Guaifenesin…Expectorant, Alcohol Free, 8 FL OZ (237 mL) bottle, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne PA 19087, UPC 8-40986-03789-4.
    Lots / codes
    Lot # SD23033, Exp 04/30/2025
    Distribution
    MI, PA
    Quantity
    4,176 bottles
    Recall started
    December 28, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0215-2024
  • Class II Ongoing

    Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-3551…

    Reason: CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.

    Seaway Pharma Inc. · Oxymetazoline Hydrochloride

    Lots, distribution and details
    Product
    Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.
    Lots / codes
    Lot # SD23032, Exp 04/30/2026
    Distribution
    MI, PA
    Quantity
    7,992 bottles
    Recall started
    December 28, 2023 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0214-2024
  • Class III Terminated

    Eprontia (topiramate) oral solution, 25 mg/mL, 473 mL Bottle, Rx only, Manufactured for: Azurity Pharmaceuticals, Woburn, MA 01801, NDC 52652-9001-1

    Reason: Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.

    Azurity Pharmaceuticals, Inc. · Topiramate

    Lots, distribution and details
    Lots / codes
    Lot #: MB22020B, Exp 12/27/2023
    Distribution
    USA nationwide.
    Quantity
    2,220 bottles
    Recall started
    December 8, 2023 (Voluntary: Firm initiated)
    Severity
    Not likely to cause health problems — for example a labelling or packaging fault.
    FDA recall number
    D-0213-2024

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update November 4, 2026 02:40. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement